title: Management of iatrogenic crystalline lens injury occurred during intravitreal injection.
abstract: To evaluate the approach to management of iatrogenic crystalline lens injury occurred during intravitreal injection (IVI). The patients who were managed operatively or followed-up without intervention after the iatrogenic lens injury due to IVI were included in the study. Capsular breaks remained either quiescent or resulted in cataract formation in the patients with inadvertent crystalline lens capsule damage. Phacoemulsification surgery was performed in patients with cataract formation with lower fluidic settings. A total of 9 cases included in the study. Seven cases underwent phacoemulsification with intraocular lens implantation. Two cases remained as quiescent lens injury during the follow-up. In 2 cases, dislocation of lens fragments occurred during phacoemulsification where pars plana vitrectomy was performed at the same session. After iatrogenic crystalline lens injury, capsular damage could remain quiescent or progress to cataract formation. Although phacoemulsification surgery can be performed with appropriate parameters, lens fragment dislocation can be observed in cases with traumatic lens damage secondary to IVI.
authors.affiliation: Department of Ophthalmology, Umraniye Training and Research Hospital, Elmalıkent Mah. Adem Yavuz Cad. No: 1, Umraniye, 34764, Istanbul, Turkey.
authors.forename: Gurkan
authors.initials: G
authors.lastname: Erdogan
authors.affiliation: Department of Ophthalmology, Umraniye Training and Research Hospital, Elmalıkent Mah. Adem Yavuz Cad. No: 1, Umraniye, 34764, Istanbul, Turkey. drbetulonal@yahoo.com.
authors.forename: Betul Onal
authors.initials: BO
authors.lastname: Gunay
authors.affiliation: Department of Ophthalmology, Umraniye Training and Research Hospital, Elmalıkent Mah. Adem Yavuz Cad. No: 1, Umraniye, 34764, Istanbul, Turkey.
authors.forename: Cihan
authors.initials: C
authors.lastname: Unlu
authors.affiliation: Department of Ophthalmology, Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital, Istanbul, Turkey.
authors.forename: Murat
authors.initials: M
authors.lastname: Gunay
authors.affiliation: Department of Ophthalmology, Umraniye Training and Research Hospital, Elmalıkent Mah. Adem Yavuz Cad. No: 1, Umraniye, 34764, Istanbul, Turkey.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Ergin
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000068258:Bevacizumab / Q000627:therapeutic use; D002386:Cataract / Q000209:etiology*; D015807:Eye Injuries, Penetrating / Q000209:etiology / Q000601:surgery*; D005260:Female; D006801:Humans; D007049:Iatrogenic Disease; D058449:Intravitreal Injections / Q000009:adverse effects*; D019654:Lens Implantation, Intraocular; D007908:Lens, Crystalline / Q000293:injuries*; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014821:Vitrectomy; D057135:Wet Macular Degeneration / Q000188:drug therapy
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab
keywords: Iatrogenic lens injury; Intravitreal injection; Quiescent lens injury; Surgery